Encouraging interim data from the world’s first clinical trial examining the safety of neural stem cell treatment in ischemic stroke patients has been reported by researchers ahead of an application for Phase II trials.
Get Started for FREE
Sign up with Facebook Sign up with Twitter
I don't have a Facebook or a Twitter account
Your new post is loading...
Your new post is loading...
|
|